Shivaey Medibutors Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 31-07-2024
- Paid Up Capital ₹ 2.50 M
as on 31-07-2024
- Company Age 25 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 2.81 Cr
as on 31-07-2024
- Satisfied Charges ₹ 2.36 Cr
as on 31-07-2024
- Revenue -5.46%
(FY 2023)
- Profit 3.06%
(FY 2023)
- Ebitda 15.91%
(FY 2023)
- Net Worth 8.68%
(FY 2023)
- Total Assets 10.38%
(FY 2023)
About Shivaey Medibutors
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 2.50 M.
The company currently has active open charges totaling ₹2.81 Cr. The company has closed loans amounting to ₹2.36 Cr, as per Ministry of Corporate Affairs (MCA) records.
Poonam Sareen and Sanjeev Sareen serve as directors at the Company.
- CIN/LLPIN
U45303DL1999PTC102510
- Company No.
102510
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
22 Nov 1999
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, Delhi, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Shivaey Medibutors?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Poonam Sareen  | Director | 22-Nov-1999 | Current |
| Sanjeev Sareen | Director | 22-Nov-1999 | Current |
Financial Performance of Shivaey Medibutors.
Shivaey Medibutors Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 5.46% decrease. The company also saw a slight improvement in profitability, with a 3.06% increase in profit. The company's net worth moved up by a moderate rise of 8.68%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Shivaey Medibutors?
In 2023, Shivaey Medibutors had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 06 Mar 2021 | ₹2.81 Cr | Open |
Yes Bank Limited Creation Date: 08 Sep 2011 | ₹1.66 Cr | Satisfied |
Icici Bank Limited Creation Date: 28 Sep 2006 | ₹7.00 M | Satisfied |
How Many Employees Work at Shivaey Medibutors?
Unlock and access historical data on people associated with Shivaey Medibutors, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Shivaey Medibutors, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Shivaey Medibutors's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
